1
/
of
0
FDA Immunogenicity Study Documents for ANDA 215503 (LIRAGLUTIDE) Approved Dec 23, 2024
FDA Immunogenicity Study Documents for ANDA 215503 (LIRAGLUTIDE) Approved Dec 23, 2024
Regular price
$69.00 USD
Regular price
Sale price
$69.00 USD
Unit price
/
per
Original Request: A copy documents in the summary basis of approval relevant to any Immunogenicity Studies conducted for the approval of ANDA 215503 (LIRAGLUTIDE) approved on December 23, 2024.
Tags: Pharma, ANDA, 2024
Tags: Pharma, ANDA, 2024
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. IMPORTANT: The FDA FOIA office operations are currently suspended. We are happy to make the request but do not know when we will receive a response. Learn more about Fast-Track Requests here.
View full details